中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Synthesis and structure-activity relationship study of pyrazolo[3,4-d]pyrimidines as tyrosine kinase RET inhibitors

文献类型:期刊论文

作者Wang, Chengyan1; Liu, Hongchun3; Song, Zilan2; Ji, Yinchun3; Xing, Li2; Peng, Xia3; Wang, Xisheng1; Ai, Jing3; Geng, Meiyu3; Zhang, Ao2
刊名BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
出版日期2017-06-01
卷号27期号:11页码:2544-2548
关键词Tyrosine kinase RET Pyrazolo[3,4-d]pyrimidine Anticancer Cell proliferation Structure-activity relationship
ISSN号0960-894X
DOI10.1016/j.bmcl.2017.03.088
文献子类Article
英文摘要Three series of pyrazolo[3,4-d]pyrimidine derivatives were synthesized and evaluated as RET kinase inhibitors. Compounds 23a and 23c were identified to show significant activity both in the biochemical and the BaF3/CCDC6-RET cell assays. Compound 23c was found to significantly inhibit RET phosphorylation and down-stream signaling in BaF3/CCDC6-RET cells, confirming its potent cellular RET-targeting profile. Different from other RET inhibitors with equal potency against KDR that associated with severe toxicity, 23c did not show significant KDR-inhibition even at the concentration of 1 mu M. These results demonstrated that 23c is a potent and selective RET inhibitor. (C) 2017 Elsevier Ltd. All rights reserved.
WOS关键词MEDULLARY-THYROID CANCER ; POTENT INHIBITOR ; CABOZANTINIB ; DERIVATIVES ; ONCOGENE
资助项目Chinese NSF[81430080] ; Chinese NSF[81373277] ; Chinese NSF[81473243] ; National Program on Key Basic Research Project of China[2015CB910603] ; Key Program of the Frontier Science of the Chinese Academy of Sciences[160621] ; [GJHZ1622]
WOS研究方向Pharmacology & Pharmacy ; Chemistry
语种英语
WOS记录号WOS:000402023800053
出版者PERGAMON-ELSEVIER SCIENCE LTD
源URL[http://119.78.100.183/handle/2S10ELR8/272649]  
专题药理学第一研究室
中科院受体结构与功能重点实验室
新药研究国家重点实验室
药物化学研究室
通讯作者Wang, Xisheng; Ai, Jing; Zhang, Ao
作者单位1.Univ Sci & Technol China, Nano Sci & Technol Inst, Suzhou 215123, Peoples R China;
2.Chinese Acad Sci, SIMM, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China;
3.Chinese Acad Sci, SIMM, Div Antitumor Pharmacol, State Key Lab Drug Res, Shanghai 201203, Peoples R China
推荐引用方式
GB/T 7714
Wang, Chengyan,Liu, Hongchun,Song, Zilan,et al. Synthesis and structure-activity relationship study of pyrazolo[3,4-d]pyrimidines as tyrosine kinase RET inhibitors[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS,2017,27(11):2544-2548.
APA Wang, Chengyan.,Liu, Hongchun.,Song, Zilan.,Ji, Yinchun.,Xing, Li.,...&Zhang, Ao.(2017).Synthesis and structure-activity relationship study of pyrazolo[3,4-d]pyrimidines as tyrosine kinase RET inhibitors.BIOORGANIC & MEDICINAL CHEMISTRY LETTERS,27(11),2544-2548.
MLA Wang, Chengyan,et al."Synthesis and structure-activity relationship study of pyrazolo[3,4-d]pyrimidines as tyrosine kinase RET inhibitors".BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 27.11(2017):2544-2548.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。